PortfoliosLab logo
LEGN vs. COST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LEGN and COST is 0.59, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

LEGN vs. COST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Legend Biotech Corporation (LEGN) and Costco Wholesale Corporation (COST). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

LEGN:

-0.65

COST:

1.29

Sortino Ratio

LEGN:

-0.63

COST:

1.81

Omega Ratio

LEGN:

0.93

COST:

1.24

Calmar Ratio

LEGN:

-0.48

COST:

1.65

Martin Ratio

LEGN:

-0.94

COST:

4.74

Ulcer Index

LEGN:

32.43%

COST:

6.04%

Daily Std Dev

LEGN:

51.22%

COST:

22.13%

Max Drawdown

LEGN:

-63.80%

COST:

-53.39%

Current Drawdown

LEGN:

-62.16%

COST:

-3.28%

Fundamentals

Market Cap

LEGN:

$5.33B

COST:

$461.51B

EPS

LEGN:

-$1.18

COST:

$17.68

PS Ratio

LEGN:

7.32

COST:

1.72

PB Ratio

LEGN:

5.24

COST:

18.04

Total Revenue (TTM)

LEGN:

$728.30M

COST:

$205.57B

Gross Profit (TTM)

LEGN:

$477.12M

COST:

$27.77B

EBITDA (TTM)

LEGN:

-$153.44M

COST:

$8.41B

Returns By Period

In the year-to-date period, LEGN achieves a -11.03% return, which is significantly lower than COST's 13.80% return.


LEGN

YTD

-11.03%

1M

-14.75%

6M

-31.19%

1Y

-27.64%

3Y*

-11.87%

5Y*

N/A

10Y*

N/A

COST

YTD

13.80%

1M

4.25%

6M

7.29%

1Y

29.10%

3Y*

32.50%

5Y*

29.64%

10Y*

24.24%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Legend Biotech Corporation

Costco Wholesale Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

LEGN vs. COST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LEGN
The Risk-Adjusted Performance Rank of LEGN is 2121
Overall Rank
The Sharpe Ratio Rank of LEGN is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of LEGN is 1919
Sortino Ratio Rank
The Omega Ratio Rank of LEGN is 2020
Omega Ratio Rank
The Calmar Ratio Rank of LEGN is 2020
Calmar Ratio Rank
The Martin Ratio Rank of LEGN is 2828
Martin Ratio Rank

COST
The Risk-Adjusted Performance Rank of COST is 8585
Overall Rank
The Sharpe Ratio Rank of COST is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of COST is 8282
Sortino Ratio Rank
The Omega Ratio Rank of COST is 8181
Omega Ratio Rank
The Calmar Ratio Rank of COST is 9090
Calmar Ratio Rank
The Martin Ratio Rank of COST is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LEGN vs. COST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Legend Biotech Corporation (LEGN) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current LEGN Sharpe Ratio is -0.65, which is lower than the COST Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of LEGN and COST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

LEGN vs. COST - Dividend Comparison

LEGN has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 0.46%.


TTM20242023202220212020201920182017201620152014
LEGN
Legend Biotech Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
COST
Costco Wholesale Corporation
0.46%0.49%2.87%0.76%0.54%3.38%0.86%1.08%4.81%1.09%4.06%0.97%

Drawdowns

LEGN vs. COST - Drawdown Comparison

The maximum LEGN drawdown since its inception was -63.80%, which is greater than COST's maximum drawdown of -53.39%. Use the drawdown chart below to compare losses from any high point for LEGN and COST.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

LEGN vs. COST - Volatility Comparison

Legend Biotech Corporation (LEGN) has a higher volatility of 16.80% compared to Costco Wholesale Corporation (COST) at 5.12%. This indicates that LEGN's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

LEGN vs. COST - Financials Comparison

This section allows you to compare key financial metrics between Legend Biotech Corporation and Costco Wholesale Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20212022202320242025
195.05M
63.72B
(LEGN) Total Revenue
(COST) Total Revenue
Values in USD except per share items

LEGN vs. COST - Profitability Comparison

The chart below illustrates the profitability comparison between Legend Biotech Corporation and Costco Wholesale Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%100.0%20212022202320242025
63.4%
15.1%
(LEGN) Gross Margin
(COST) Gross Margin
LEGN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Legend Biotech Corporation reported a gross profit of 123.71M and revenue of 195.05M. Therefore, the gross margin over that period was 63.4%.

COST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Costco Wholesale Corporation reported a gross profit of 9.61B and revenue of 63.72B. Therefore, the gross margin over that period was 15.1%.

LEGN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Legend Biotech Corporation reported an operating income of -50.65M and revenue of 195.05M, resulting in an operating margin of -26.0%.

COST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Costco Wholesale Corporation reported an operating income of 2.32B and revenue of 63.72B, resulting in an operating margin of 3.6%.

LEGN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Legend Biotech Corporation reported a net income of -100.92M and revenue of 195.05M, resulting in a net margin of -51.7%.

COST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Costco Wholesale Corporation reported a net income of 1.79B and revenue of 63.72B, resulting in a net margin of 2.8%.